Efficiency and Safety of Patent Ductus Arteriosus Surgical Ligation in Extremely Low Birth Weight Infants Without Chest Tube Placement

Abstract

Patent ductus arteriosus (PDA) has been associated with increased morbidity and mortality in preterm infants. Surgical ligation (SL) is generally performed in symptomatic infants when medical management is contraindicated or has failed. We retrospectively reviewed our institution's experience in surgical management of PDA for extremely low birth weight (ELBW) infants without chest tube placement assessing its efficiency and safety. We evaluated 17 consecutive ELBW infants undergoing SL for symptomatic PDA (January 2012–January 2018) with subsequent follow-up for 6 months postdischarge. Patients consisted of 9 (53%) females and 8 (47%) males. Mean gestational age (GA) at birth was 27.9 ± 2.1 weeks. Median values for surgical age (SA) from birth to operation was 10 days (interquartile range [IQR]: 8–12); PDA diameter 3.4 mm (IQR: 3.2–3.5); surgical weight (SW) 750 g (IQR: 680–850); and days of mechanical ventilation (DMV) as estimated by Kaplan–Meier curve 22 days (95% confidence interval: 14.2–29.8). We observed a statistically significant negative association between DMV and GA at birth (rho = − 0.587, p = 0.017), SA (rho = − 0.629, p = 0.009) and SW (rho = − 0.737, p = 0.001). One patient experienced left laryngeal nerve palsy confirmed by laryngoscopy. Otherwise, there were no adverse events to include surgical-related mortality, recurrence of PDA, or need for chest tube placement during follow-up. SL of PDA in ELBW infants without chest tube placement is both efficient and safe. Universal consensus recommendations for the management of PDA in ELBW neonates are needed. Further study is required regarding the use of the less invasive option of percutaneous PDA closure in ELBW infants.

Keywords

birth, premature - infant, extremely low birth weight - ductus arteriosus, patent - chest tube

Publikationsverlauf

Eingereicht: 15. März 2021

Angenommen: 28. Mai 2021

Artikel online veröffentlicht:
07. Juli 2021

• References

• 1 Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125 (05) 1020-1030
• 2 Foster M, Mallett LH, Govande V. et al. Short-term complications associated with surgical ligation of patent ductus arteriosus in ELBW infants: a 25-year cohort study. Am J Perinatol 2021; 38 (05) 477-481
• 3 Mezu-Ndubuisi OJ, Agarwal G, Raghavan A, Pham JT, Ohler KH, Maheshwari A. Patent ductus arteriosus in premature neonates. Drugs 2012; 72 (07) 907-916
• 4 Noori S, McCoy M, Friedlich P. et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123 (01) e138-e144
• 5 Weisz DE, Giesinger RE. Surgical management of a patent ductus arteriosus: Is this still an option?. Semin Fetal Neonatal Med 2018; 23 (04) 255-266
• 6 Aru GM, Dabbs AP, Cummins ER. et al. Selective use of chest tubes in thoracotomies for congenital cardiovascular procedures. Ann Thorac Surg 1999; 68 (04) 1376-1378 , discussion 1378–1379
• 7 Arya H, Williams J, Ponsford SN, Bissenden JG. Neonatal diaphragmatic paralysis caused by chest drains. Arch Dis Child 1991; 66 (4 Spec No): 441-442
• 8 Kebba N, Mwambu T, Oketcho M, Izudi J, Obuku EA. Chest closure without drainage after open patent ductus arteriosus ligation in Ugandan children: a nonblinded randomized controlled trial. BMC Surg 2016; 16 (01) 69
• 9 Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews 2018; 19 (07) e394-e402
• 10 Almeida-Jones M, Tang NY, Reddy A, Zahn E. Overview of transcatheter patent ductus arteriosus closure in preterm infants. Congenit Heart Dis 2019; 14 (01) 60-64
• 11 Backes CH, Rivera BK, Bridge JA. et al. Percutaneous patent ductus arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics 2017; 139 (02) e20162927
• 12 Backes CH, Giesinger RE, Rivera BK. et al. Percutaneous closure of the patent ductus arteriosus in very low weight infants: considerations following US food and drug administration approval of a novel device. J Pediatr 2019; 213: 218-221
• 13 Sathanandam SK, Gutfinger D, O'Brien L. et al. Amplatzer Piccolo occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheter Cardiovasc Interv 2020; 96 (06) 1266-1276
• 14 Taylor R, Forbes MJ, Kobayashi D. Transcatheter closure of patent ductus arteriosus in a tiniest baby – 510 grams. Prog Pediatr Cardiol 2020; 57: 101189
• 15 Ngo S, Profit J, Gould JB, Lee HC. Trends in patent ductus arteriosus diagnosis and management for very low birth weight infants. Pediatrics 2017; 139 (04) e20162390
• 16 Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics 2014; 133 (04) e1024-e1046
• 17 Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A.. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150 (03) 229-234, 234.e1
• 18 Weisz DE, Mirea L, Rosenberg E. et al. Association of patent ductus arteriosus ligation with death or neurodevelopmental impairment among extremely preterm infants. JAMA Pediatr 2017; 171 (05) 443-449
• 19 Alexander F, Chiu L, Kroh M, Hammel J, Moore J. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. J Pediatr Surg 2009; 44 (01) 112-117, 117
• 20 Tashiro J, Perez EA, Sola JE. Reduced hospital mortality with surgical ligation of patent ductus arteriosus in premature, extremely low birth weight infants: a propensity score-matched outcome study. Ann Surg 2016; 263 (03) 608-614
• 21 Fonseca E, Georgiev SG, Gorenflo M, Loukanov TS. Patent ductus arteriosus in preterm infants: benefits of early surgical closure. Asian Cardiovasc Thorac Ann 2014; 22 (04) 391-396
• 22 Ito S, Matsuda T, Usuda H. et al. Surgical ligation for patent ductus arteriosus in extremely premature infants: strategy to reduce their risk of neurodevelopmental impairment. Tohoku J Exp Med 2016; 240 (01) 7-13
• 23 Vida VL, Lago P, Salvatori S. et al. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?. Ann Thorac Surg 2009; 87 (05) 1509-1515 , discussion 1515–1516
• 24 Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg 2006; 81 (01) 231-234
• 25 Naik-Mathuria B, Chang S, Fitch ME. et al. Patent ductus arteriosus ligation in neonates: preoperative predictors of poor postoperative outcomes. J Pediatr Surg 2008; 43 (06) 1100-1105
• 26 Strychowsky JE, Rukholm G, Gupta MK, Reid D. Unilateral vocal fold paralysis after congenital cardiothoracic surgery: a meta-analysis. Pediatrics 2014; 133 (06) e1708-e1723
• 27 Engeseth MS, Olsen NR, Maeland S, Halvorsen T, Goode A, Røksund OD. Left vocal cord paralysis after patent ductus arteriosus ligation: a systematic review. Paediatr Respir Rev 2018; 27: 74-85
• 28 Clement WA, El-Hakim H, Phillipos EZ, Coté JJ. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg 2008; 134 (01) 28-33